Source: Biocare Blog

Biocare Blog Empire Genomics Corp. awarded Molecular Analyzers, Reagents agreement with Premier, Inc.

Buffalo, New York - April 1, 2024 - Empire Genomics Corp has been awarded a national group purchasing agreement for Molecular Analyzers, Reagents with Premier, Inc. Effective 02/01/2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for FISH (Fluorescent in situ Hybridization) Probes. [...]The post Empire Genomics Corp. awarded Molecular Analyzers, Reagents agreement with Premier, Inc. appeared first on Biocare Medical.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Luis de Luzuriaga's photo - CEO of biocare medical

CEO

Luis de Luzuriaga

CEO Approval Rating

90/100

Read more